Literature DB >> 18991091

Modification of the composition of articular cartilage collagen fibrils with increasing age.

Anne Vaughan-Thomas1, Jayesh Dudhia, Michael T Bayliss, Karl E Kadler, Victor C Duance.   

Abstract

Recent studies have identified a range of interactions between type IX collagen and other cartilage matrix components. To determine the extent to which these interactions are important in maintaining the integrity of ageing articular cartilage, we analyzed an age range of normal healthy articular cartilage samples by Western blotting, immunohistochemical, and PCR analyses. Reduced levels of type IX collagen were detected in post adolescence cartilage. Type IX collagen epitopes were evident throughout the matrix in all cartilage samples up to 19 years of age. Post adolescence, however, the pattern of immunoreactivity revealed territorial staining only. Type IX collagen expression at the transcriptional level is maintained at all ages. Type IX collagen fragments were extracted from young tissue, supporting the hypothesis that young cartilage is continually remodelled, while mature cartilage maintains relatively low levels of collagen turnover. Clearly the age changes we observed may have significant effects on the integrity of the tissue as the chondrocytes in ageing articular cartilage have limited capacity to turnover the interterritorial matrix. However, this study provides evidence that even in old age, the chondrocyte attempts to maintain its pericellular environment and hence its mechanical role. Therefore, the potential of type IX collagen to interact with other matrix components continues to be of importance in the territorial environment, and these interactions may have significant roles in mechanotransduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991091     DOI: 10.1080/03008200802325417

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  7 in total

1.  Epigenetically mediated spontaneous reduction of NFAT1 expression causes imbalanced metabolic activities of articular chondrocytes in aged mice.

Authors:  M Zhang; Q Lu; B Egan; X-B Zhong; K Brandt; J Wang
Journal:  Osteoarthritis Cartilage       Date:  2016-02-20       Impact factor: 6.576

2.  Type IX collagen interacts with fibronectin providing an important molecular bridge in articular cartilage.

Authors:  Philippa Parsons; Sophie J Gilbert; Anne Vaughan-Thomas; David A Sorrell; Rebecca Notman; Mark Bishop; Anthony J Hayes; Deborah J Mason; Victor C Duance
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

Review 3.  The Extracellular Matrix of Articular Cartilage Controls the Bioavailability of Pericellular Matrix-Bound Growth Factors to Drive Tissue Homeostasis and Repair.

Authors:  Tonia L Vincent; Oliver McClurg; Linda Troeberg
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

4.  Postnatal development of collagen structure in ovine articular cartilage.

Authors:  Mark C van Turnhout; Henk Schipper; Bas Engel; Willem Buist; Sander Kranenbarg; Johan L van Leeuwen
Journal:  BMC Dev Biol       Date:  2010-06-07       Impact factor: 1.978

5.  Maturation-Related Changes in T2 Relaxation Times of Cartilage and Meniscus of the Pediatric Knee Joint at 3 T.

Authors:  Jie C Nguyen; Hailey Allen; Fang Liu; Kaitlin M Woo; Zhaoye Zhou; Richard Kijowski
Journal:  AJR Am J Roentgenol       Date:  2018-10-09       Impact factor: 3.959

6.  Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids.

Authors:  Jörg Jerosch
Journal:  Int J Rheumatol       Date:  2011-08-02

7.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures.

Authors:  Tamás Juhász; Eszter Szentléleky; Csilla Szűcs Somogyi; Roland Takács; Nóra Dobrosi; Máté Engler; Andrea Tamás; Dóra Reglődi; Róza Zákány
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.